EDTA Chelation IV 150MG / ML – 50ml Information
EDTA Chelation IV 150MG / ML – 50ml
Product Results: Alzheimer’s disease, angina, high blood pressure, high cholesterol, multiple sclerosis, peripheral artery disease, rheumatoid arthritis, band Keratopathy.
WE OFFER NO DOSING PROTOCOLS ON THIS ITEM, EDTA CHELATION IV, AS IT IS STRICTLY TO BE ADMINISTERED BY REGISTERED NURSE OR DOCTOR. RESEARCH PEPTIDES SOUTH AFRICA IS NOT RESPONSIBLE FOR ANY ANAPHYLACTIC OR OTHERWISE LIFE THREATENING CONSEQUENCES AS A RESULT OF USE OF THESE PRODUCTS
| Weight | 1 g |
|---|---|
| Dimensions | 8 × 4 × 8 cm |
Only logged in customers who have purchased this product may leave a review.
Related products
Achieve the highest state of cognitive functioning. Help stroke victims recover brain function. Aid neural regeneration in the case of Alzheimer’s
Intravenous Drips
Critical role in metabolism and thyroid function and helps protect your body from damage caused by oxidative stress. Boost your immune system, slow age-related mental decline, reduce your risk of heart disease. treatment of Hashimoto’s thyroiditis and to treat high cholesterol
Peptides
Anti depressant. Stroke Recovery.TREK-1 inhibitor. Assists with mood, memory and learning. Aids muscle function
Intravenous Drips
Weak bones (osteoporosis), a type of “tired blood” (anemia), and symptoms of premenstrual syndrome (PMS). Osteoarthritis.
Learning and memory improvement. Increased sensory attention. Increased curiosity. Increased mental clarity. Restoration of balance of serotonergic and noradrenergic brain system activity. Anti-anxiety. Antiviral activity. Psychostimulant. Anti-asthenic. Increased mental energy. Stabilization of mood and overall feeling of wellbeing. Reversal of anhedonia. Potential restoration of catecholaminergic system functions after damage due to drug abuse
Intravenous Drips
Reduces oxidative stress, may improve psoriasis. Reduces cell damage in alcoholic and nonalcoholic fatty liver disease. Improves insulin resistance in older individuals. Increases mobility for people with peripheral artery disease. Reduces symptoms of Parkinson’s disease. May help fight against autoimmune disease. May reduce oxidative damage in children with autism. May reduce the impact of uncontrolled diabetes. May reduce respiratory disease symptoms
Peptides
CJC-1295 DAC (Modified Growth Hormone-Releasing Factor 1-29 Drug Affinity Complex) – 2MG per vial
Long Release - Increased growth hormone secretion and IGF-1 Levels with no increase in prolactin. Increased body weight and length through increased protein synthesis. Increased muscle growth and bone density. Improved immune function, cognition and memory. Increased collagen production, fat loss and cellular repair and regeneration.
Intravenous Drips
Human Subjects: Reduce your risk of chronic disease, help manage high blood pressure, lower your risk of heart disease, reduce blood uric acid levels and help prevent gout attacks, helps prevent iron deficiency, boosts immunity.
Reviews
There are no reviews yet.